CY1112150T1 - Μαλακτικη συνθεση - Google Patents

Μαλακτικη συνθεση

Info

Publication number
CY1112150T1
CY1112150T1 CY20111101201T CY111101201T CY1112150T1 CY 1112150 T1 CY1112150 T1 CY 1112150T1 CY 20111101201 T CY20111101201 T CY 20111101201T CY 111101201 T CY111101201 T CY 111101201T CY 1112150 T1 CY1112150 T1 CY 1112150T1
Authority
CY
Cyprus
Prior art keywords
composition
rtm
vaseline
water
petroleum jelly
Prior art date
Application number
CY20111101201T
Other languages
English (en)
Inventor
Pierre Fabre
Christophe Przybylski
Jean-François Cordoliani
Marion Kopec
Original Assignee
Pierre Fabre Dermo-Cosmetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Dermo-Cosmetique filed Critical Pierre Fabre Dermo-Cosmetique
Publication of CY1112150T1 publication Critical patent/CY1112150T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Developing Agents For Electrophotography (AREA)

Abstract

Η εφεύρεση αναφέρεται σε μια μαλακτική σύνθεση τοπικής χρήσης η οποία περιέχει ως ενεργό παράγοντα έναν συνδυασμό γλυκερίνης, βαζελίνης και υγρής παραφίνης με τη μορφή γαλακτώματος ελαίου εντός ύδατος ή ύδατος εντός ελαίου, στην χρησιμοποίηση της για την παρασκευή ενός φαρμάκου προοριζόμενου για την θεραπεία των παθήσεων δερματικής ξηρότητας ορισμένων δερματίτιδων, όπως η ατοπική δερματίτητης, καταστάσεις ιχθύωσης, η ψωρίαση, στην χρησιμοποίηση της για την παρασκευή ενός φαρμάκου προοριζόμενου για την θεραπεία των επιφανειακών εγκαυμάτων μικρής έκτασης, και στην χρησιμοποίηση της για την παρασκευή ενός φαρμάκου, προοριζόμενου για την πρόληψη και/ή θεραπεία/μείωση της συχνότητας και της έντασης των εκζεματικών εξάρσεων που παρατηρούνται στους ασθενείς οι οποίοι έχουν προσβληθεί από ατοπική δερματίτιδα.
CY20111101201T 2008-05-16 2011-12-05 Μαλακτικη συνθεση CY1112150T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0853187A FR2931073B1 (fr) 2008-05-16 2008-05-16 Composition emolliente
EP09290370A EP2119435B1 (fr) 2008-05-16 2009-05-18 Composition emolliente

Publications (1)

Publication Number Publication Date
CY1112150T1 true CY1112150T1 (el) 2015-12-09

Family

ID=40028914

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111101201T CY1112150T1 (el) 2008-05-16 2011-12-05 Μαλακτικη συνθεση

Country Status (27)

Country Link
US (1) US20110071226A1 (el)
EP (2) EP2323639A1 (el)
JP (1) JP5653911B2 (el)
KR (1) KR20110023858A (el)
CN (2) CN102026632A (el)
AT (1) ATE523192T1 (el)
AU (1) AU2009248047B2 (el)
BR (1) BRPI0912506B1 (el)
CA (1) CA2724522A1 (el)
CY (1) CY1112150T1 (el)
DK (1) DK2119435T3 (el)
ES (1) ES2370465T3 (el)
FR (1) FR2931073B1 (el)
GE (1) GEP20135900B (el)
HK (1) HK1203828A1 (el)
HR (1) HRP20110905T1 (el)
IL (1) IL209334A (el)
MA (1) MA32396B1 (el)
MX (1) MX2010012352A (el)
NZ (1) NZ589971A (el)
PL (1) PL2119435T3 (el)
PT (1) PT2119435E (el)
RU (1) RU2493834C2 (el)
SI (1) SI2119435T1 (el)
UA (1) UA101035C2 (el)
WO (1) WO2009138517A1 (el)
ZA (1) ZA201009033B (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2241351A1 (en) * 2009-04-16 2010-10-20 Orfagen Pharmaceutical composition comprising glycerol, white soft paraffin and liquid paraffin for the treatment of uremic xerosis
FR2957260B1 (fr) * 2010-03-15 2012-04-27 Fabre Pierre Dermo Cosmetique Nouvelle formulation dermocorticoide
CN102488624B (zh) * 2011-12-13 2013-12-04 中山市天图精细化工有限公司 用于个人护理的凡士林气雾剂组合物
EP2845591A1 (en) * 2013-09-04 2015-03-11 Polichem S.A. Use of trifluoroacetic acid as keratolytic agent to treat hyperkeratotic skin lesions
FR3013985B1 (fr) * 2013-12-03 2017-11-03 Galephar M/F Compositions hydratantes comprenant au moins un extrait de caesalpinia spinosa, avec au moins de la vaseline et de la glycerine
DE102013225372A1 (de) * 2013-12-10 2015-06-11 Henkel Ag & Co. Kgaa Wärmende Öl-Haarkur
FR3024360A1 (fr) * 2014-07-30 2016-02-05 Pf Medicament Emulsions aux stearates
FR3090385B1 (fr) 2018-12-21 2021-01-08 Pf Medicament Composition émolliente sous forme d’émulsion

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2023786B2 (de) * 1970-05-15 1973-03-01 Wasser-in-oel-emulgatoren
SU925990A1 (ru) * 1980-06-26 1982-05-07 Уфимский Нефтяной Институт Способ получени медицинского вазелина
IL69353A0 (en) * 1983-07-27 1984-01-31 Berman Daniel Skin ointment comprising herbal extracts
PL162396B3 (pl) * 1989-12-07 1993-10-30 Akademia Medyczna Im Mikolaja Krem chroniacy skóre przed wodnymi roztworami elektrolitów PL
US5512278A (en) * 1994-01-11 1996-04-30 Phylomed Corporation Ointment base useful for pharmaceutical preparations
EP1035832B1 (en) * 1997-12-03 2002-09-11 JOHNSON & JOHNSON CONSUMER COMPANIES, INC. Skin care composition with improved skin hydration capability
FR2826659B1 (fr) * 2001-07-02 2005-11-11 Aldivia Substitut de lanoline, son procede d'obtention et ses applications
FR2831443B1 (fr) 2001-10-30 2005-02-11 Oreal Utilisation d'extraits vegetaux pour ameliorer la fonction barriere de la peau
FR2847467B1 (fr) 2002-11-25 2006-05-26 Oreal UTILISATION D'UN AGENT MODULATEUR DE L'ACTIVITE DE L'OXYSTEROL 7alpha-HYDROXYLASE POUR LE TRAITEMENT COSMETIQUE DE DESORDRES CUTANES
CN1552303A (zh) * 2003-06-03 2004-12-08 张金铎 美白霜及其制备方法
CN1927157A (zh) * 2005-09-08 2007-03-14 天津市世雄科技发展有限公司 夏令驱虫防晒油膏
FR2905857B1 (fr) 2006-09-20 2011-02-11 Chanel Parfums Beaute Utilisation d'un extrait de pulpe de caroube pour hydrate la peau

Also Published As

Publication number Publication date
BRPI0912506B1 (pt) 2019-04-16
SI2119435T1 (sl) 2011-11-30
ZA201009033B (en) 2012-01-25
JP2011520850A (ja) 2011-07-21
AU2009248047A1 (en) 2009-11-19
IL209334A0 (en) 2011-01-31
IL209334A (en) 2015-08-31
HK1203828A1 (en) 2015-11-06
UA101035C2 (ru) 2013-02-25
DK2119435T3 (da) 2011-11-21
PL2119435T3 (pl) 2012-01-31
MX2010012352A (es) 2010-12-07
CN104189005A (zh) 2014-12-10
CA2724522A1 (fr) 2009-11-19
WO2009138517A1 (fr) 2009-11-19
EP2119435A1 (fr) 2009-11-18
AU2009248047B2 (en) 2014-07-17
FR2931073A1 (fr) 2009-11-20
ES2370465T3 (es) 2011-12-16
GEP20135900B (en) 2013-08-12
HRP20110905T1 (hr) 2011-12-31
EP2323639A1 (fr) 2011-05-25
ATE523192T1 (de) 2011-09-15
CN102026632A (zh) 2011-04-20
RU2010153201A (ru) 2012-06-27
MA32396B1 (fr) 2011-06-01
PT2119435E (pt) 2011-12-09
EP2119435B1 (fr) 2011-09-07
KR20110023858A (ko) 2011-03-08
NZ589971A (en) 2013-01-25
BRPI0912506A2 (pt) 2015-10-13
US20110071226A1 (en) 2011-03-24
RU2493834C2 (ru) 2013-09-27
JP5653911B2 (ja) 2015-01-14
FR2931073B1 (fr) 2010-08-20

Similar Documents

Publication Publication Date Title
CY1112150T1 (el) Μαλακτικη συνθεση
CR10169A (es) "uso de derivados de sulfamida heterociclica benzo-fusionada para disminuir lipidos y disminuir niveles de glucosa en la sangre"
FR2890559B1 (fr) Mousses dermatologiques a base de metronidazole et emulsions pour la preparation
CL2009000555A1 (es) Compuestos derivados de tetramatos sustituidos espirociclicamente con 4'4'-dioxaespiro; procedimiento de preparacion; agente para combatir plagas y/o vegetaciones indeseadas que comprende dichos compuestos; su procedimiento de preparacion y uso; composiciones y su uso
AR072961A1 (es) Forma cristalina de (2s)-(-)-n-(6-cloro-2,3-dihidro-benzo[1,4]dioxin-2-ilmetil)-sulfamida
ATE459338T1 (de) Formulierungen für benzimidazolylpyridylether
NO20074252L (no) Forbindelser og anvendelser derav
NO20091517L (no) Emulsjon
WO2008013669A3 (en) Alpha hydroxy acid sustained release formulation
Man et al. A topical Chinese herbal mixture improves epidermal permeability barrier function in normal murine skin
WO2008027533A3 (en) Personal care compositions comprising pear seed extract
DE602006018436D1 (de) Gleitmittelzubereitung
WO2020084599A3 (en) New ammonium salts of fluorinated organic acids, method of their synthesis and application
WO2012084605A3 (en) Leave-on composition comprising a laponite and an essential oil
FR2909556B1 (fr) Creme photoprotectrice a base d'acide gras
WO2006076119A3 (en) Treatment of skin diseases
WO2012147084A3 (en) Oxymetazoline for the treatment of ano-rectal disorders
ATE496628T1 (de) Verwendung von lecithin als arzneimittel zur behandlung von psoriasis
WO2004093832A3 (fr) Composition cosmetique ou pharmaceutique comprenant l’association d’au moins un diacylglycerol et d’au moins un alcool gras
UY30153A1 (es) Uso de derivados de benzo-heteroaril sulfamida para disminuir lipidos y disminuir los niveles de glucosa en sangre
Kavak et al. The effects of high-rate frequency modulation treatment on malondialdehyde in diabetic polineuropaty
Sirenko et al. Morphologic study of liver and pancreatic parenchyma in conditions of L-arginine-induced acute pancreatitis
Jang et al. The Regulation of NMDA-induced N-cadherin Cleavage in Cortical Neurons
TN2010000533A1 (fr) Composition emolliente
TH68815A (th) สารผสมสำหรับซ่อมแซมผิวหนังที่บาดเจ็บ